Adamis Pharmaceuticals Corporation Profile Avatar - Palmy Investing

Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candid…

Drug Manufacturers - Specialty & Generic
US, San Diego [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
Dorbin John W. Jr.
General Counsel
11/02/23 [Form 4]
Cohen Seth
CFO
10/25/23 [Form 4]
Versi Ebrahim
CEO
Also inside the BofD
09/19/23 [Form 4]
Moss Ronald B.
Chief Medical Officer
03/22/22 [Form 4]
Marguglio David J.
SVP and Chief Business Officer
Also inside the BofD
03/22/22 [Form 4]
Carlo Dennis J Phd
President & CEO
Also inside the BofD
03/22/22 [Form 4]
Benedicto David C.
Chief Financial Officer
03/22/22 [Form 4]
Hopkins Robert O
Chief Financial Officer
02/23/21 [Form 4]
Daniels Karen K.
VP of Operations
02/16/21 [Form 5]
End of ADMP's Analysis
CIK: 887247 CUSIP: 00547W208 ISIN: US00547W2089 LEI: - UEI: -
Secondary Listings
ADMP has no secondary listings inside our databases.